Safety and Efficacy of Ga68 Αvβ3 IAC PET/CT for Diagnosis and Clinical Management in Angiogenic Breast Cancer Patients
Phase 1
Not yet recruiting
- Conditions
- Angiogenic Breast Cancer
- Interventions
- Diagnostic Test: Ga-68-PEG-Αvβ3-IAC
- First Posted Date
- 2020-07-21
- Last Posted Date
- 2024-05-20
- Lead Sponsor
- Advanced Imaging Projects, LLC
- Target Recruit Count
- 25
- Registration Number
- NCT04480619
- Locations
- 🇮🇳
Postgraduate Institute of Medical and Research, Chandigarh, India
🇮🇳All India Institute of Medical Sciences, New Delhi, India
🇿🇦University of Witwatersrand, Johannesburg, South Africa
A Phase I/II Multicenter, Open-Label Study of Lu-177-DOTAGA-IAC, for the Treatment of Angiogenic Breast Cancer Patients.
Phase 1
Not yet recruiting
- Conditions
- Breast Cancer Stage IV
- Interventions
- Drug: Lutetium-177-DOTAGA-IAC
- First Posted Date
- 2020-07-13
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- Advanced Imaging Projects, LLC
- Target Recruit Count
- 100
- Registration Number
- NCT04469127
- Locations
- 🇮🇳
Postgraduate Institute of Medical and Research, Chandigarh, India
🇿🇦CM Johannesburg Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa
© Copyright 2025. All Rights Reserved by MedPath